Company Profiles

driven by the PitchBook Platform

Anaeropharma Science

Description

Developer of novel therapeutics and platform technology designed to create more effective and safer therapies. The company's proprietary platform technology, in situ Delivery and Production System or i-DPS, develops novel therapeutics for cancers based on recombinant bifidobacterium, enabling researchers to target hypoxic environment in solid cancers.

2004

Founded

PRIVATE

Status

11-50

Employees

Series A

Latest Deal Type

$28.1M

Latest Deal Amount

$36.6M

Total Amount Raised

Description

Developer of novel therapeutics and platform technology designed to create more effective and safer therapies. The company's proprietary platform technology, in situ Delivery and Production System or i-DPS, develops novel therapeutics for cancers based on recombinant bifidobacterium, enabling researchers to target hypoxic environment in solid cancers.

Website:

www.anaeropharma.co.jp

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology
Pharmaceuticals

Primary Office

4th Floor, Yaesu KH Building, 19-8, Nihonbashi Kabuto-cho, Chuo-ku Tokyo, 103-0026Japan +81 (0)33 356 1910
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Anaeropharma Science's full profile, request a free trial.

Anaeropharma Science Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Anaeropharma Science Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Hachijuni CapitalOtherMinority000 0000000 0000
Innovation Network Corporation of JapanPE/BuyoutMinority000 0000000 0000
Mitsui Global InvestmentCorporate Venture CapitalMinority000 0000000 0000
ORIX Growth CapitalCorporate Venture CapitalMinority000 0000000 0000
The Dow Chemical CompanyCorporationMinority000 0000000 0000
Hachijuni Capital Other
Innovation Network Corporation of Japan PE/Buyout
Mitsui Global Investment Corporate Venture Capital
ORIX Growth Capital Corporate Venture Capital
The Dow Chemical Company Corporation

Anaeropharma Science Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Tetsuya MishimaChief Executive Officer, President and Director
Yuji Yamada Ph.DDirector
Noriaki Kurata Ph.DSenior Director
Nobutake MoriiDirector
Takehiko SawabeDirector
Tetsuya Mishima Chief Executive Officer, President and Director
Yuji Yamada Ph.D Director
Noriaki Kurata Ph.D Senior Director
Nobutake Morii Director
Takehiko Sawabe Director

Anaeropharma Science Board Members (3)

NameRepresentingRoleSinceContact
Info
Minoru Fujimori Ph.DAnaeropharma ScienceCo-Founder & Director000 0000
Shun’ichiro Taniguchi Ph.DAnaeropharma ScienceCo-Founder & Director000 0000
Tetsuya MishimaAnaeropharma ScienceChief Executive Officer, President and Director000 0000
Minoru Fujimori Ph.D Co-Founder & Director Anaeropharma Science
Shun’ichiro Taniguchi Ph.D Co-Founder & Director Anaeropharma Science
Tetsuya Mishima Chief Executive Officer, President and Director Anaeropharma Science
Request full access to PitchBook